Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-409-1 | CAS number: 95-31-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: inhalation
Administrative data
- Endpoint:
- short-term repeated dose toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- other information
- Reliability:
- 3 (not reliable)
- Rationale for reliability incl. deficiencies:
- significant methodological deficiencies
- Remarks:
- Accpetable documented study report with restriction (test substance purity not indicated; the study is limited concerning the recommended particle-size distribution given in current guidelines and thus an exposure of all relevant regions of the respiratory tract was presumably not given. The biologically relevance of findings from this study, especially systemic effects are questionable, whereas local effects noted in the inhalation study could be used for supporting purpose.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 981
- Report date:
- 1981
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 412 (Subacute Inhalation Toxicity: 28-Day Study)
- Principles of method if other than guideline:
- In a four-week pilot inhalation study male and female rats were exposed to the dust atmosphere of Santocure NS 6 (N-tert-butylbenzothiazole-2-sulphenamide) hours per day, 5 days per week for 20 or 21 exposures during a 29-day experimental period. The mean nominal exposure concentrations for groups III, IV and V were 0.058, 0.172 or 0.524 mg/liter, respectively. The equivalent aerodynamic diameter was 8.4 micrometers.
- GLP compliance:
- no
- Limit test:
- no
Test material
- Reference substance name:
- N-tert-butylbenzothiazole-2-sulphenamide
- EC Number:
- 202-409-1
- EC Name:
- N-tert-butylbenzothiazole-2-sulphenamide
- Cas Number:
- 95-31-8
- Molecular formula:
- C11H14N2S2
- IUPAC Name:
- N-(1,3-benzothiazol-2-ylsulfanyl)-2-methylpropan-2-amine
- Details on test material:
- Santocure NS, lot no. MIC 270582
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
Administration / exposure
- Route of administration:
- inhalation
- Type of inhalation exposure:
- whole body
- Vehicle:
- air
- Mass median aerodynamic diameter (MMAD):
- 8.4 µm
- Remarks on MMAD:
- MMAD / GSD: aerodynamic mass medium diameter: 8.4 micrometer with a geometric standard deviation of 4.31
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- The concentration of the airborne dusts in the chamber atmosphere was determined analytically using the fiberglass filter sampling technique.
- Duration of treatment / exposure:
- 4 weeks
- Frequency of treatment:
- 6 hours/day, 5 days/week
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0.0, 0.0024, 0.029, and 0.084 mg/l
Basis:
- No. of animals per sex per dose:
- 10 animals per dose and sex
- Control animals:
- yes
- Details on study design:
- Post-exposure period: no
- Positive control:
- None.
Examinations
- Observations and examinations performed and frequency:
- Clinical signs (ocular and nasal irritation, respiratory distress), body weights, food consumption, clinical chemistry, hematology, biochemistry, urinalysis.
- Sacrifice and pathology:
- At the termination of the study the rats from all groups were sacrificed for gross and histopathological examinations.
- Statistics:
- All statistical analysis compared the treatment group with the control group.
Results and discussion
Results of examinations
- Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- Nasal irritation was observed in the rats and ranged in severity from slight to marked. The symptom was usually present after exposure and had generally disappeared by the following morning. The severity of nasal irritation appeared to be concentration dependent during the first half of the study, several rats in the highest dose group exhibited an urogenital discharge. This symptom was observed after exposure and was still apparent the following morning. Alopecia was observed in two rats of the highest dose group.
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Description (incidence and severity):
- No effects.
- Food consumption and compound intake (if feeding study):
- no effects observed
- Description (incidence and severity):
- No effects.
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- no effects observed
- Description (incidence and severity):
- No effects.
- Clinical biochemistry findings:
- effects observed, treatment-related
- Description (incidence and severity):
- at 0.029 and 0.084 mg/l: SGOT values for males and females were significant elevated compared to control (II).
at 0.0024 mg/l: SGOT values were comparable to control all other parameters appeared comparable to one or both control groups. - Urinalysis findings:
- no effects observed
- Description (incidence and severity):
- No effects.
- Behaviour (functional findings):
- not examined
- Immunological findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Description (incidence and severity):
- Some variations in absolute and rel. weights, but the variations did not appear to be dose dependent and there were no compound related microscopic alterations associated with the involved tissue, therefore the biological signifcance of the variations could not be determined
- Gross pathological findings:
- no effects observed
- Description (incidence and severity):
- No gross lesions interpreted as compound induced observed in any animal at necropsy.
- Neuropathological findings:
- not examined
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Description (incidence and severity):
- 0.084 mg/l: brown pigments within sinusoidal macrophages in lymph nodes (6/20)was slightly increased when compared to controls (2 control I, 1 control II)concurrent erythrophagocytosis in the lymph nodes was also slightly increased in the Santocure NS treated group (4/20) as compared to controls (0 control T, 1 control II) Very slight to moderate focal to multifocal hepatocellular necrosis was observed in 3/20 animals; an associated acute inflammatory infiltrate was present in 2 of the 3 affected animals. This lesions was not present in controls While the previously described lesions may represent a compound effect, they have been observed in control rats at the facility and therefore the possibility that they are spontaneous in origin cannot be excluded.
The occurence and incidence of all other microscopic lesions were similar to that observed in controls. - Histopathological findings: neoplastic:
- not examined
Effect levels
- Dose descriptor:
- other:
- Effect level:
- 0.029 mg/L air
- Sex:
- male/female
- Basis for effect level:
- other: see 'Remark'
- Remarks on result:
- not measured/tested
- Remarks:
- Effect level not specified
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
Nominal concentrations: 0.058, 0.17 and 0.52 mg/l
Analytical concentrations: mean analytical concentrations: 0.0024, 0.029 and 0.084 mg/l
Gravimetric concentrations: mean gravimetric concentrations: 0.0024, 0.028, 0.088 mg/l
Dust particle size distribution analyses: the equivalent aerodynamic mass medium diameter: 8.4 µm , geometric standard deviation of 4.31
Clinical studies Appearance and general behavior: Nasal irritation was observed in the rats and ranged in severity from slight to marked. The symptom was usually present after exposure and had generally disappeared by the following morning. The severity of nasal irritation appeared to be concentration dependent during the first half of the study, several rats in the highest dose group exhibited an urogenital discharge. This symptom was observed after exposure and was still apparent the following morning. Alopecia was observed in two rats of the highest dose group.
Body weights: no effects.
Food consumption: no time or test material related differences were observed.
Hematology: no effects.
Blood chemistry:
at 0.029 and 0.084 mg/l: SGOT values for males and females were significant elevated compared to control (II).
at 0.0024 mg/l: SGOT values were comparable to control all other parameters appeared comparable to one or both control groups.
Urinalysis: no effects.
Gross pathology: No gross lesions interpreted as compound induced observed in any animal at necropsy.
Organ weights: Some variations in absolute and rel. weights, but the variations did not appear to be dose dependent and there were no compound related microscopic alterations associated with the involved tissue, therefore the biological signifcance of the variations could not be determined.
Histopathology: 0.084 mg/l: brown pigments within sinusoidal macrophages in lymph nodes (6/20)was slightly increased when compared to controls (2 control I, 1 control II)concurrent erythrophagocytosis in the lymph nodes was also slightly increased in the Santocure NS treated group (4/20) as compared to controls (0 control T, 1 control II) Very slight to moderate focal to multifocal hepatocellular necrosis was observed in 3/20 animals; an associated acute inflammatory infiltrate was present in 2 of the 3 affected animals. This lesions was not present in controls While the previously described lesions may represent a compound effect, they have been observed in control rats at the facility and therefore the possibility that they are spontaneous in origin cannot be excluded.
The occurence and incidence of all other microscopic lesions were similar to that observed in controls.
Histological examinations of treated animals (highest dose group) of the nasal turbinate area, trachea, lung and olfactory bulb revealed no biologically relevant differences compared to the controls.
Applicant's summary and conclusion
- Conclusions:
- Study is limited concerning the recommended particle-size distribution given in current guidelines and thus an exposure of all relevant regions of the respiratory tract was presumably not given. The biologically relevance of findings from this study, especially systemic effects are questionable.
- Executive summary:
In a four-week pilot inhalation study male and female rats were exposed to the dust atmosphere of Santocure NS 6 (N-tert-butylbenzothiazole-2-sulphenamide) hours per day, 5 days per week for 20 or 21 exposures during a 29-day experimental period. The mean nominal exposure concentrations for groups III, IV and V were 0.058, 0.172 or 0.524 mg/liter, respectively. The equivalent aerodynamic diameter was 8.4 micrometers.
The study is limited concerning the recommended particle-size distribution given in current guidelines and thus an exposure of all relevant regions of the respiratory tract was presumably not given. The biologically relevance of findings from this study, especially systemic effects are questionable.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.